Content on Demand for Special Sections and Niche Publications
Men ages 55 to 69 should talk with their health care provider about prostate-specific antigen (PSA)-based screening for prostate cancer. That's according to new recommendations from the
Clinicians inform men ages 55 to 69 years about the potential benefits and harms of prostate-specific antigen (PSA)-based screening for prostate cancer. Many men will experience potential harms of screening, including false-positive results that require additional workup, overdiagnosis and overtreatment, and treatment complications, such as incontinence and impotence.
The task force recommends against PSA-based screening for prostate cancer in these men age 70 years and older.
"The recommendations don't change for men over 70. If men over 70 are asymptomatic with no family history, they don't' need to have PSA tests every year," says
The PSA blood test is the most common method to screen for prostate cancer. Tollefson says there are benefits of PSA prostate cancer screening, but it's not risk-free.
"Screening men from ages 55 to 69 is the benefit of catching a cancer earlier, when it's easier to treat and potentially cure," he says. "If men are screened, then, potentially, that tumor can be identified when it's at a curable state. Then, they can undergo curative treatment and reduce their risk of dying of prostate cancer.
"The risk of being screened, in a lot of ways, comes with the risk of being treated. If a man is screened, and the test shows he is at risk of prostate cancer, frequently, the next step is to get a prostate biopsy. There is a small, but real risk of infection to arise after a biopsy. Then, with treatment - both with radiation as well as surgery - the risk of incontinence and erectile dysfunction can be a real issue for some men."
Prostate cancer is the third leading cause of cancer death in American men. The
(Mayo Clinic News Network is your source for health news, advances in research and wellness tips.)
(c)2017 Mayo Foundation for Medical Education and Research Distributed by
PHOTO (for help with images, contact 312-222-4194):
You have 0 items in your Shopping Cart